The modern methods of diagnosis of cervical neoplasia: the clinical-and-economic efficiency

Badalova L.A.; Rogovskaia S.I.

doi:https://doi.org/

Badalova L.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii Pervogo moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Rogovskaia S.I.

kafedra akusherstva i ginekologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

The modern methods of diagnosis of cervical neoplasia: the clinical-and-economic efficiency

Authors:

Badalova L.A., Rogovskaia S.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2012;(2): 27‑32

Read: 2006 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Badalova LA, Rogovskaia SI. The modern methods of diagnosis of cervical neoplasia: the clinical-and-economic efficiency. Russian Journal of Human Reproduction. 2012;(2):27‑32. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)

Использование инфографики авторами научных работ

References:

Daling J.R., Madeleine M.M., Schwartz S.M., Shera K.A., Carter J.J., McKnight B. et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84: 263-270.
Farkhry C., Gillison M.L. Clinical implications of human papillomavirus in head and neck cancer. J Clin Oncol 2006; 24: 2606-2611.
Goffin F., Mayrand M.H., Gauthier P., Alobaid A., Lussier C., Provencher D. et al. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol 2006; 78: 814-819.
Gross G., Phisher H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and genital warkts. Med Microbiol Immunol 2004; 193: 35-44.
Munoz N., Bosh F.X., Castellsague X. et al. Int J Cancer 2004; 11: 1: 278-285.
Castle P.E., Solomon D., Schiffman M., Wheeler C.M. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005; 97: 1066.
Khan M.J., Castle P.E., Lorincz A.T. et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072.
Kjaer S.K., van den Brule A.J., Paull G. et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325: 572.
Moore E.E., Danielewski J.A., Garland S.M. et al. Clearance of human papillomavirus in women treated for cervical dysplasia. Obstet Gynecol 2011; 117: 101.
Rodríguez A.C., Schiffman M., Herrero R. et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100: 513.
Wright T.C., Cox J.T. Human papillomaviruses - natural history of infections. In: Clinical uses of human papillomavirus (HPV) DNA testing. Am Soc Colposcopy Cervical Pathol 2004.
ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin N109: Cervical cytology screening. Obstet Gynecol 2009; 114: 1409.
Wright T.C.Jr., Schiffman M., Solomon D., Cox J.T., Garcia F., Goldie S., Hatch K., Noller K.L., Roach N., Runowicz C., Saslow D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 2: 304-309.
Franco E.L., Duarte-Franco E., Ferenczy A. Cervical cancer: epidemiology, prevention, and role of human papillomavirus infection. Can Med Ass J 2001; 164: 1017-1025.
Ronco G., Cuzick J., Pierotti P. et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007; 335: 28.
Scherman M.E., Lorincz A.T., Scott D.R. et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Nat Cancer Ins 2003; 95: 46-52.
Avtandilov G.G., Glukhova Yu.K., Shabalova I.P. Ploidometricheskaya diagnostika predrakovykh protsessov i raka sheiki matki po tsitologicheskim preparatam. Klin lab diagnost 2004; 11: 45-47.
ASCUS-LSIL Traige Srudy (ALTS) Group. A randomized trial on the managemtnt of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393.
Cuzick J., Clavel C., Petry K.U. et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Sancer 2006; 119: 1095.
Denny L.A., Wright T.C.Jr. Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol 2005; 19: 501.
Kim J.J., Wright T.C., Goldie S.J. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005; 97: 888.
Koliopoulos G., Arbyn M., Martin-Hirsch P. et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and metaanalysis of non-randomized studies. Gynecol Oncol 2007; 104: 232.
Mayrand M.H., Duarte-Franco E., Rodrigues I. et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. Department of Oncology and Epidemiology and Biostatistics, McGill University, Montreal, Canada. N Engl J Med 2007; 357: 16: 1579-1588.
Dallenbach-Hellweg G., Trunk M.J., Von Knebel Doeberitz M. Traditional and new molecular methods for early detection of cervical cancer. Arch Pathol 2004; 5: 35-39.
Klaes R., Benner A., Friedrich T. et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389-1399.
Klaes R., Friedrich T., Spitkovsky D. et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284.
Ivanyan A.N., Kryukovskii S.B., Melekhova N.Yu., Gurova T.Yu. Mat' i ditya. M: MEDI Ekspo 2006; 340-341.
Rogovskaya S.I., Podzolkova N.M., Goncharevskaya Z.L. Prfilaktika raka sheiki matki: novye tekhnologii. Prilozhenie. Doktor Ru 2011;9: 68: 14-17.
Gel'tser B.I. i dr. Farmakoekonomicheskie issledovaniya v zdravookhranenii. Pod red. B.I. Gel'tsera. Vladivostok: Dal'nauka 2002; 272.
Vorob'ev P.A., Avksent'eva M.V., Yur'ev A.S., Sura M.V. Kliniko-ekonomicheskii analiz. M: N'YuDIAMED 2004.
Vorob'ev P.A., Avksent'eva M.V., Borisenko O.V. i dr. Kliniko-ekonomicheskii analiz. M: N'YuDIAMED 2008; 778.